Viewing Study NCT06299995


Ignite Creation Date: 2025-12-24 @ 1:18 PM
Ignite Modification Date: 2025-12-27 @ 10:09 PM
Study NCT ID: NCT06299995
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-03-19
First Post: 2024-02-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phenotype and Burden of a Midfacial Segment Pain
Sponsor: Swiat Zdrowia
Organization:

Study Overview

Official Title: Cross-sectional, Multicentre and Multidisciplinary Study Describing Phenotype and Burden of a Midfacial Segment Pain
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to describe midfacial segment pain phenotype, burden and comorbidities in a multicentre and multidisciplinary setting. The ultimate goal is a comprehensive description of this type of pain allowing for its implementation in future classifications.

This cross-sectional study is designed to describe midfacial segment pain in a clinical setting. Patients from rhinologic, headache and facial pain or oral medicine/dentistry secondary care centres will be recruited during a one year period. Individuals with other facial pain according to current classification such as sinonasal disorders, neoplasms, local infections, history of significant trauma associated with pain onset will be excluded. Data will be collected through a structured questionnaire covering pain characteristics, coexisting diagnoses, pain-related burden and consequences, physical examination and paranasal sinuses imaging.
Detailed Description: https://journals.sagepub.com/doi/10.1177/25158163241235642

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: